Fig. 3: Profiling of the clinical cohort.

A Distribution of ctDNA detection and ctDNA level estimation across all cohort’ samples. B PFS results stratifying samples based on availability of ctDNA level estimation at T1. C PFS results stratifying samples based on availability of ctDNA level estimation at T0 or T1. D OS results stratifying samples based on availability of ctDNA level estimation at T0. E OS results stratifying samples based on availability of ctDNA level estimation at T0 or T1. F Landscape of genome-wide SCNAs detected across all cohort’s samples. G Landscape of focal SCNAs detected across all cohort’s samples.